“…The results showed that ETP/PTX-loaded SMEDDS significantly enhanced the bioavailability compared with suspension formulation. In addition to P-gp and CYP3A inhibition, the other possible reasons for increased bioavailability may include: (a) SMEDDS maintained the drug in a solubilized state in the gastrointestinal tract and thus improved the oral bioavailability of poorly water-soluble drugs (Wu, Wang, et al, 2006); (b) the increased surface area of small droplets contributed to a significant increase in drug absorption (Shahnaz, Hartl, et al, 2011;Zhao, Huang, et al, 2013); and (c) droplets with a diameter size of <50 nm in SMEDDS dispersed rapidly in blood and lymph (Amri, Le Clanche, et al, 2014), and lymphatic transport can bypass the first-pass effect (Weerapo, Limmatvapira, et al, 2015). The tissue distribution results of ETP and PTX are presented in Figure 3.…”